Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
JMAC Maxpro Capital Acquisition Corp
10.454+0.034+0.33%
Close
02/03 16:00 ET
High
10.460
Open
10.460
Turnover
3.14K
Low
10.441
Pre Close
10.420
Volume
300.00
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Maxpro Capital Acquisition Confirms Additional Funding, Extension Of Deadline To Complete Initial Business Combination
Maxpro Capital Acquisition Confirms Additional Funding, Extension Of Deadline To Complete Initial Business Combination
Maxpro Capital Acquisition Extends Deadline to Complete Business Combination
04:41 AM EST, 01/11/2023 (MT Newswires) -- Maxpro Capital Acquisition (JMAC) said late Tuesday its sponsor MP One Investment has asked to extend the deadline by which Maxpro has to complete a business
Maxpro Capital Acquisition Announces Extension To Deadline To Complete Business Combination, Says Sponsor Requested To Extend Date By Which Co. Has To Consummate Business Combination From Jan. 13 To Apr. 13
Maxpro Capital Acquisition Announces Extension To Deadline To Complete Business Combination, Says Sponsor Requested To Extend Date By Which Co. Has To Consummate Business Combination From Jan. 13 To A
Maxpro Capital Acquisition Corp. Announces Extension To Deadline To Complete Business Combination
Maxpro Capital Acquisition Corp. (NASDAQ:JMAC) (the "Company"), announced today that its sponsor, MP One Investment LLC (the "Sponsor"), has requested that the Company extend the date by which the Com
Apollomics Vebreltinib Gets FDA Orphan Drug Status for Lung Cancer Subtype
Apollomics Inc. Receives FDA Orphan Drug Designation For Vebreltinib For Treatment Of Non-Small Cell Lung Cancer With MET Genomic Tumor Aberrations
Apollomics Inc. (NASDAQ:JMAC), an innovative biopharmaceutical company committed to the discovery and development of mono- and combination-oncology therapies, today announced that the U.S. Food and Dr
Maxpro Capital Acquisition Confirms Additional Funding, Extension of Deadline
Maxpro Capital Acquisition Extends It Deadline to Complete Business Combination
Maxpro Capital Acquisition (NASDAQ:JMAC) has announced that its sponsor, MP One Investment, has requested to extend the date by which the Co. has to consummate a business combination from Oct. 13, 202
Maxpro Capital Acquisition Corp. Shares Resume Trade Following Circuit Breaker Halt At $10.19
Maxpro Capital Acquisition Corp. Shares Resume Trade Following Circuit Breaker Halt At $10.19
Apollomics To Be Listed on Nasdaq Through Business Combination With Maxpro Capital Acquisition Corp.; Transaction Values Apollomics At Pre-Money Equity Value Of $899M
Apollomics Inc. ("Apollomics" or the "Company"), a late-stage clinical biopharmaceutical company, and Maxpro Capital Acquisition Corp. ("Maxpro") (NASDAQ:JMAC, , JMACU, , JMACW))))) today announced
Company Overview
More
Maxpro Capital Acquisition Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on June 2, 2021 and is headquartered in Taipei City, Taiwan.
CEO： Mr. Hong-Jung Chen
Market： NASDAQ
Listing Date： 10/08/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet